TransMedics Group (TMDX) Tops Q2 EPS by 14c ; Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to TransMedics Group (TMDX) Tops Q2 EPS by 14c ; Offers Guidance

TransMedics Group (TMDX) PT Raised to $200 at Oppenheimer

August 1, 2024 6:04 AM EDT

Oppenheimer analyst Suraj Kalia raised the price target on TransMedics Group (NASDAQ: TMDX) to $200.00 (from $125.00) while maintaining a Outperform rating.

The analyst comments "TransMedics reported 2Q24 revs. of $114.3M, blowing past our/consensus $100.2M/$98.8M estimates. In Q2, ~126 (+21 seq.; ~55 liver, ~57 heart, ~14 lung) transplant... More